Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Colinz Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Colinz Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Colinz Laborator Q4 net profit up 7.14% at Rs 0.15 cr

    16 May 2025, 6:00PM The company reported standalone net profit of Rs 0.15 crore for the quarter ended March 31, 2025 as compared to Rs 0.14 crore in the same period last
  • Colinz Laborator - Integrated Filing (Financial)

    16 May 2025, 5:54PM Pursuant to SEBI Circular dated 31-12-2024 read with BSE circular no 20250102-4 we are submitting herewith our Integrated Filing (Financial) for the Q
  • Colinz Laborator - Board Meeting Outcome for Outcome Of The Board Meeting

    16 May 2025, 5:45PM In terms of provisions of Regulation 30 (read with Part A of Schedule III) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
  • Colinz Laborator - Outcome Of The Board Meeting

    16 May 2025, 5:43PM As per Regulation 30 of SEBI (LODR)Regulation,2015 uploading our Audited Financial Results for the Quarter and Year Ended on 31-03-2025. Kindly tak
  • Colinz Laborator - Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) R

    7 May 2025, 3:49PM Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider
  • Colinz Laborator has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    10 Apr 2025, 4:40PM As of March 2025, 65.94% is owned by Indian Promoters and 34.06% by Public. <p align=justify> Top five Promoters holding highest number of shares of C
  • Colinz Laborator - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2025, 4:49PM Please find the attached certificate under Regulation 74(5) of SEBI(Regulationss0 , 2018 for the Quarter ended Mar-2025 received form our RTA M/s. BIg
  • Colinz Laborator - Confirmation Of Not Being Identified As Large Corporate In Terms Of SEBI Circular No. SEBI/H

    3 Apr 2025, 5:12PM with reference to the captioned subject we Colinz Laboratories Ltd (the Company) , do hereby confirm that we do not fulfill the criteria mentioned at
  • Colinz Laborator - Non - Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of SEBI (LODR) Regulation

    3 Apr 2025, 4:25PM This is to inform you that Annual Secretarial Compliance under Regulation 24A of SEBI(LODR), Regulation, 2018, read with SEBI circular dated 8/2/2019
  • Colinz Laborator - Annual Disclosure Of Encumberances Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And

    3 Apr 2025, 4:17PM Annual Disclosure of eccumberances under Regulation 31(4) of SEBI(Substantial Acquisition of Shares and takeovers) regulation, 2011 for the year ended
  • Colinz Laborator - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9)

    2 Apr 2025, 6:21PM As required under Regulation 15(2) of SEBI(LODR) , Regulations,2015. Compliance with the provisions as specified in Regulation 17 to 27 and Clauses
  • Colinz Laborator - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviation O

    2 Apr 2025, 6:12PM As per the Regulation 32 of SEBI(LODR) of Regulation ,2015 ( statement of Deviation or Variation for proceeds of Public issue , rights,(QIP) , is not
  • Colinz Laborator - Integrated Filing (Financial)

    4 Mar 2025, 11:44AM Pursuant to SEBI Cercular No SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31-12-2024 read with BSE circular 20250102-4, we are submitting herewith the I

Key fundamentals

Evaluate the intrinsic value of Colinz Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 10.1153 9.5187 8.4126 8.1719 8.2838
Liabilities 10.1153 9.5187 8.4126 8.1719 8.2838
Equity 2.5191 2.5191 2.5191 3.545 3.545
Gross Profit 0.4951 0.5428 0.6089 0.5861 0.1406
Net Profit 0.4966 0.4867 0.4574 0.3393 0.2075
Cash From Operating Activities -1.4536 1.0347 0.4029 0.4671 2.158
NPM(%) 7.6 6.92 6.39 4.86 3.37
Revenue 6.5277 7.0296 7.1549 6.9742 6.1589
Expenses 6.0326 6.4868 6.546 6.3881 6.0183
ROE(%) 5.24 5.13 4.82 3.58 2.19

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Colinz Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.05 -1.12 26.88 32.53 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.39 0.39 308.58 118.54 14.01 0.68
Bharat Immunological and Biologicals Corporation Ltd 25.66 -5.45 0.00 246.13 -39.50 0.00
Astec Lifesciences Ltd 698.00 -1.87 0.00 111.77 -687.11 0.00

Company Info

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Read More

Parent Organisation

Colinz Laboratories Ltd.

Founded

06/10/1986

Managing Director

NSE Symbol

FAQ

The current price of Colinz Laboratories Ltd is

The 52-week high for Colinz Laboratories Ltd is

The market capitalization of Colinz Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Colinz Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Colinz Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Colinz Laboratories Ltd shares.

The CEO of Colinz Laboratories Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT